16.58 USD
↗ 0.51 (3.17%)AT CLOSE (11:59 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
16.58
↘ 0.01 (0.03%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
16.58
↘ 0.01 (0.03%)
Market: CLOSED
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $16.58. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place AVTX at a fair price relative to peers.
Technical & fundamental data as of Sep 16, 2026.
Open?$16.17
High?$16.70
Low?$15.87
Prev. Close?$16.07
Volume?1.4M
Avg. Volume?832.5K
VWAP?$16.42
Rel. Volume?1.74x
Bid / Ask
Bid?$14.33 × 100
Ask?$19.01 × 100
Spread?$4.68
Midpoint?$16.67
Valuation & Ratios
Market Cap?861.8M
Shares Out?53.6M
Float?51.8M
Float %?96.6%
P/E Ratio?N/A
P/B Ratio?1.92
EPS?-$1.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
861.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?11.17Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?23.91%Squeeze Risk
Short Interest?12.4M
Days to Cover?15.2
Free Float51.8M
Avg Daily Volume816.6K
Settlement Date2026-08-31
Financial Health
Current Ratio?19.31Strong
Quick Ratio?19.31Strong
Cash Ratio?4.04Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.92CHEAP▾
Peers100
S&P76
P/S?14,607.35HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.5CHEAP▾
S&P97
EV/Sales?13,160.20HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-22.4%WEAK▾
S&P7
ROA?-20.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-68290000
Enterprise Value?$776.5M
Fundamentals ratios updated end of day